EconTalk
EconTalk

Paul Romer on the COVID-19 Pandemic

In this bonus episode of EconTalk, economist and Nobel Laureate Paul Romer discusses the coronavirus pandemic with EconTalk host Russ Roberts. Romer argues that the status quo of shutdown and fear of infection is unsustainable. Returning to normal requires an inexpensive, quick, and relatively painl

Featured Speakers

Library of Economics and Liberty Host

Topics Discussed

Episode Summary

Executive Summary: Russ Roberts and Paul Romer discuss COVID-19 in mid-May 2020, arguing that both blanket lockdowns and simple herd-immunity mitigation are extremely costly. Romer’s main remedy is large-scale, frequent, fast testing to identify infectious people and isolate them while preserving most normal activity. They also explore FDA barriers, prize incentives, the political risks of prolonged shutdowns, and how the pandemic may reshape labor markets and globalization.

Main Topics: Lockdown vs. mitigation vs. suppression: Romer contrasts two broad strategies: letting the virus spread until herd immunity (mitigation) or suppressing transmission indefinitely. He argues both are hugely costly and that society needs a more sustainable middle path. Mass testing as the central policy tool: The discussion centers on frequent testing to identify who is infectious right now, enabling targeted isolation instead of broad shutdowns. Romer sees testing as the key to maintaining freedom and lowering transmission. Regulatory barriers and the FDA: Romer criticizes FDA restrictions that slowed adoption of saliva-based tests and constrained innovation to specific labs and procedures. He argues that state-level flexibility and faster approvals are needed. Economic, social, and political costs of shutdowns: Roberts and Romer emphasize that the damage from prolonged restrictions goes beyond GDP: it includes mental health strain, lost dignity, business collapse, and the risk of political destabilization. Incentives, prizes, and mobilizing capacity: They discuss using purchase commitments and large prize incentives to rapidly scale testing infrastructure, drawing on industrial logistics, labs, and private-sector problem solvers. Testing, liberty, and civil liberties: They debate how to use positive-test information without authoritarian overreach. Romer prefers voluntary compliance, limited quarantine, and market-based/counterparty rules over digital surveillance. Globalization, trade, and future pandemic defense: Romer argues that while global mobility helps spread disease, restricting trade and travel too heavily would sacrifice important freedoms. Better testing infrastructure would function as a long-run defense against future outbreaks. Labor market dislocation and reallocation: The conversation closes on how restaurant and service jobs disappeared overnight and may not return quickly. Romer suggests temporary public jobs and income support to preserve dignity while recovery proceeds.

Key Arguments: The pandemic caused a major, largely irreversible shock: humanity lost opportunities that cannot simply be restored by reopening. Mitigation that lets the virus spread slowly could still take more than a year and produce very large death tolls. Suppression by blanket shutdown is economically and socially unsustainable because it imposes massive ongoing costs. Frequent, cheap, rapid testing is the best low-cost way to identify infectious people and keep R below 1 without paralyzing society. Saliva-based testing could vastly expand capacity, but FDA restrictions have impeded scaling. Digital contact tracing risks privacy and centralization; simpler testing-based strategies are preferable. The political consequences of prolonged deprivation may be more dangerous than the economic losses themselves. Purchase commitments and prizes could overcome coordination failures and accelerate testing capacity. A vaccine may help, but it is uncertain and should be approved cautiously to preserve public confidence in vaccination generally. To prevent permanent labor-market scarring, society may need temporary public jobs and income support in addition to testing-based reopening.

Data Points: U.S. deaths: about 80,000 - Roberts cites the approximate U.S. COVID-19 death toll at the time of recording (mid-May 2020). U.S. unemployment rate: just under 15% - Roberts notes unemployment in the U.S. was near 15% and expected to rise further. Estimated foregone output: $500 billion per month - Romer’s rough estimate of the monthly economic cost of continued suppression/shutdown, including lost production and some future supply effects. Herd immunity threshold: at least 60% infected - Romer says herd immunity requires a large share of the population to have been infected before the virus dies out naturally. Infection fatality rate assumption: 0.5% - Romer’s back-of-the-envelope calculation for deaths under a herd-immunity path. Projected deaths under herd immunity: about 1 million - Romer estimates roughly a million deaths if 60%+ of the population is infected at a 0.5% fatality rate. Time to reach herd immunity under mitigation: 400-500 days - Romer says if deaths are limited to around 2,000 per day, it could take well over a year to reach herd immunity. Testing budget proposal: $100 billion per year - Romer suggests that annual testing investment would now be worthwhile despite seeming excessive pre-pandemic. Federal testing funds mentioned: $25 billion - Roberts notes Congress had already allocated funds for testing. Prize proposal: $1 billion - Romer proposes a billion-dollar prize for the first lab to process 10 million tests per day. Target lab throughput: 10 million tests per day - The proposed prize would reward a lab that demonstrates this processing capacity. University lab scale example: 20,000-50,000 tests per day - Roberts suggests university labs could be scaled to meaningful but still insufficient throughput. Testing interval: every 14 days - Romer uses this as an illustrative frequency for population testing in a pandemic defense system. Example test turnaround: about 4 hours - Romer says a lab can process saliva samples in roughly four hours, with logistics being the main bottleneck.

Pivotal Quotes: "we've suffered a very serious shock" — Paul Romer: Romer frames COVID-19 as a major loss of opportunities that cannot be undone. "we need to figure out something which is sustainable but a lot less costly" — Paul Romer: Romer rejects both indefinite shutdown and herd-immunity mitigation as unacceptable long-run options. "if this means a threat that could really undermine our whole democratic system and our whole rule of law, I don't think it's worth running that risk" — Paul Romer: Romer explains why prolonged pandemic restrictions could be politically destabilizing.

Implications: The episode argues for a reopening strategy built on frequent rapid testing, targeted isolation, and scaled logistics rather than broad shutdowns. For policy, it implies regulatory flexibility, prize incentives, and temporary support for displaced workers are essential to preserve both public health and civic stability.

🔓 Sign Up for Unlimited Episode Search

About EconTalk

EconTalk: Conversations for the Curious is an award-winning weekly podcast hosted by Russ Roberts of Shalem College in Jerusalem and Stanford's Hoover Institution. The eclectic guest list includes authors, doctors, psychologists, historians, philosophers, economists, and more. Learn how the health care system really works, the serenity that comes from humility, the challenge of interpreting data, how potato chips are made, what it's like to run an upscale Manhattan restaurant, what caused the...

View all episodes from EconTalk